Page last updated: 2024-08-24

isobutyramide and hydroxyurea

isobutyramide has been researched along with hydroxyurea in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gu, LH; Huisman, TH; Jansen, R; Saleh, AW; van Goethem, A; Velvis, HJ	1
Erdlenbruch, B; Kanbach, K; Monkemeyer, S; Pekrun, A; Reinhardt, D; Rönndahl, G; Witt, O	1

Trials

1 trial(s) available for isobutyramide and hydroxyurea

Article	Year
Isobutyramide therapy in patients with sickle cell anemia. American journal of hematology, 1995, Volume: 49, Issue:3 Topics: Adult; Amides; Anemia, Sickle Cell; Female; Fetal Hemoglobin; Globins; Humans; Hydroxyurea; L-Lactate Dehydrogenase; Male; Middle Aged	1995

Other Studies

1 other study(ies) available for isobutyramide and hydroxyurea

Article	Year
Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin. Blood, 2003, Mar-01, Volume: 101, Issue:5 Topics: Amides; Azacitidine; Benzamides; Butyrates; Enzyme Inhibitors; Fetal Hemoglobin; Gene Expression Regulation; Gene Expression Regulation, Leukemic; Globins; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Hydroxamic Acids; Hydroxyurea; Imidazoles; K562 Cells; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Neoplasm Proteins; p38 Mitogen-Activated Protein Kinases; Peptides, Cyclic; Phenylbutyrates; Pyridines; Vorinostat	2003

Article

Year

Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin.

Blood, 2003, Mar-01, Volume: 101, Issue:5

Topics: Amides; Azacitidine; Benzamides; Butyrates; Enzyme Inhibitors; Fetal Hemoglobin; Gene Expression Regulation; Gene Expression Regulation, Leukemic; Globins; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Hydroxamic Acids; Hydroxyurea; Imidazoles; K562 Cells; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Neoplasm Proteins; p38 Mitogen-Activated Protein Kinases; Peptides, Cyclic; Phenylbutyrates; Pyridines; Vorinostat

2003